RVP
Retractable Technologies, Inc.0.8200
-0.0124-1.49%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
24.55MP/E (TTM)
-Basic EPS (TTM)
-0.22Dividend Yield
0%Recent Filings
8-K
Declares preferred stock dividends
Retractable Technologies declared dividends totaling $57,611.25 to Series II and III Class B Convertible Preferred Stock holders, covering July 1 to September 30, 2025, at $1.00 per share annually. Payments hit on October 20, 2025, for record holders as of October 10. This move signals steady cash flow amid manufacturing safety products. Yet liquidity hangs on market access and supplier ties.
8-K
Q2 sales surge amid tariffs
Retractable Technologies reported Q2 2025 net sales of $10.4 million, up from $6.0 million last year, driven by 109.2% higher unit sales, yet operating losses narrowed to $5.1 million from $5.8 million amid tariff pressures. For the first half, sales reached $18.7 million versus $13.6 million prior, but operating losses widened to $9.8 million from $8.7 million, with $2.1 million spent on tariffs despite shifting 38% of production to the U.S. from 9%. Tariffs will materially hike future costs. A $1.9 million litigation settlement provided relief, while a $5.6 million unrealized investment loss stung.
10-Q
Q2 FY2025 results
Retractable Technologies posted Q2 sales of $10.4M, up 73.2% y/y but with a slim gross loss of $0.1M as tariff costs and inventory write-downs squeezed margins. Operating loss narrowed to $5.1M from $5.8M y/y, aided by lower bad debt and G&A expenses, while a $1.9M litigation settlement and $1.6M unrealized investment gain softened the net loss to $0.1M. EasyPoint needles drove unit volume surges, comprising 40% of Q2 sales, yet lower pricing curbed revenue gains. Cash dipped to $3.0M amid $5.2M YTD operating burn, offset by $5.0M from security sales; long-term debt stands at $1.1M with no revolver. Tariffs under Section 301 of the Trade Act of 1974, now at 130% on China-sourced syringes and needles, pose ongoing supply chain risks.
8-K
Workforce cut saves $1.6M annually
Retractable Technologies slashed its manufacturing workforce by 12.4% on July 23, 2025, targeting production and support roles to counter tariff pressures on Chinese imports. This move ramps up domestic output at its Little Elm facility, projecting $1.6 million in annual wage and benefit savings—8.6% of total workforce costs—despite $56 thousand in one-time separation payouts. Tariffs hit hard. Yet future U.S. trade policies remain unpredictable, clouding import strategies.
8-K
Declares preferred stock dividends
Retractable Technologies declared dividends totaling $57,611.25 to Series II and Series III Class B Convertible Preferred Stock holders, covering accrued amounts at $1.00 per share annually from April 1 through June 30, 2025. Payable July 21 to record holders on July 10, this move signals steady liquidity amid ongoing patent and supply chain risks. Dividends affirm commitment to preferred shareholders.
IPO
Website
Employees
Sector
Industry
AVTR
Avantor, Inc.
11.20-0.08
BAX
Baxter International Inc.
19.05-0.48
IRMD
iRadimed Corporation
96.87-0.15
MHUA
Meihua International Medical Te
7.61-6.41
RMD
ResMed Inc.
247.34-5.73
RSCF
Reflect Scientific, Inc.
0.05+0.00
RXST
RxSight, Inc.
12.76+0.24
STSS
Sharps Technology Inc.
2.22+0.00
VTAK
Catheter Precision, Inc.
2.19-0.04
WST
West Pharmaceutical Services, I
266.44-5.42